The overall goal of the Center for Single Photon-Emitting Cancer Imaging Agents at the University of Missouri-Columbia (MU) is to foster interdisciplinary research to enable development of novel radiolabeled molecular imaging agents capable of selective in vivo uptake and retention in cancer cells. The Research Components and Development Projects supported by this grant are primarily focused on identification of single-photon emitting, site-directed in vivo targeting biomolecular-conjugates directed to cell surface receptors, antigens and angiogenesis markers with high specificity. Many of the bioconjugates developed in this ICMIC are designed to allow corresponding analogues labeled with particle-emitting radionuclides to be produced for potential radiotherapeutic applications. Molecular biology and biochemical techniques form the primary approach for the design and generation of new cancer targeting vectors, including in vivo phage display, combinatorial chemistry/biochemistry, and SPPS. The In vivo Cellular and Molecular Imaging Center (ICMIC) grant will provide essential support to maintain current and catalyze expansion of research teams which are composed of scientists that combine expertise in molecular biology, chemistry, radiopharmaceutical chemistry, comparative oncology, pharmacology, tumor biology and nuclear imaging. The major thrust of the research that will be conducted in the ICMIC will involve the development of 99mTc-, 111In-and 123I-labeled SPECT imaging agents. The radiolabeled bioconjugates to be designed and studied will selectively bind with high affinity to a variety of cancers, including breast, pancreatic, melanoma, lymphoma, prostate and lung cancers. Specialized Resources (Cores) supported by the ICMIC provide critical infrastructure and expertise to support cross-disciplinary research activities conducted in the Research Components and the Development Projects. The ICMIC will facilitate expansion and enhance the scope and quality of radiopharmaceutical sciences research related to development of novel, highly specific cancer targeting imaging agents. The scientific advances made in this program will foster new interdisciplinary research programs with other investigators at both this and extramural institutions, including other ICMICs and Pre-ICMICs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA103130-04
Application #
7111095
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (M1))
Program Officer
Menkens, Anne E
Project Start
2003-08-01
Project End
2008-07-31
Budget Start
2006-08-11
Budget End
2007-07-31
Support Year
4
Fiscal Year
2006
Total Cost
$1,953,004
Indirect Cost
Name
University of Missouri-Columbia
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
153890272
City
Columbia
State
MO
Country
United States
Zip Code
65211
Srivastava, Shefali; Fergason-Cantrell, Emily A; Nahas, Roger I et al. (2016) Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors. Tetrahedron 72:6127-6135
Xu, Rong; Lord, Sarah A; Peterson, Ryan M et al. (2015) Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters. Bioorg Med Chem 23:222-30
Calzada, Victoria; Zhang, Xiuli; Fernandez, Marcelo et al. (2012) A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab. Curr Radiopharm 5:318-24
Statham-Ringen, Kimberly A; Selting, Kimberly A; Lattimer, Jimmy C et al. (2012) Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma. Am J Vet Res 73:681-8
Zhang, Xiuli; Yue, Zhiwei; Lu, Bao-Yuan et al. (2012) Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging. Curr Radiopharm 5:329-35
Newton-Northup, Jessica R; Figueroa, Said D; Deutscher, Susan L (2011) Streamlined in vivo selection and screening of human prostate carcinoma avid phage particles for development of peptide based in vivo tumor imaging agents. Comb Chem High Throughput Screen 14:9-21
Bigott-Hennkens, Heather M; Dannoon, Shorouk F; Noll, Samantha M et al. (2011) Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives. Nucl Med Biol 38:549-55
Kannan, Raghuraman; Pillarsetty, Nagavarakishore; Gali, Hariprasad et al. (2011) Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re). Inorg Chem 50:6210-9
Fitzsimmons, Jonathan M; Lever, John R; Lever, Susan Z (2011) Synthesis and ?1 Receptor Binding of Halogenated N,N'-Diphenethylethylenediamines. Med Chem (Los Angeles) 1:
Kumar, Senthil R; Gallazzi, Fabio A; Ferdani, Riccardo et al. (2010) In vitro and in vivo evaluation of ??Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. Cancer Biother Radiopharm 25:693-703

Showing the most recent 10 out of 64 publications